A rapid chromatographic method for quality control of technetium-99m-bicisate

Journal of Nuclear Medicine Technology

Volumn 25, Issue 1, 1997, Pages 49-51

  Amin, Kanak C ^a   Saha, Gopal B ^a   Go, Raymundo T ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Chromatography methods; Quality control; Technetium 99m bicisate

Indexed keywords

ACETIC ACID ETHYL ESTER; CYSTEINE ETHYL ESTER TC 99M;

ARTICLE; CONTROLLED STUDY; DRUG PURITY; INTERMETHOD COMPARISON; ISOTOPE LABELING; PAPER CHROMATOGRAPHY; QUALITY CONTROL; RADIOCHEMISTRY; TIME;

EID: 0030892793     PISSN: 00914916     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Vallabhajosula S, Zimmerman RE. Picard M. et al. Technetium-99m ECD: a new brain imaging agent: in vivo kinetics and biodistribution studies in normal human subjects. J Nucl Med 1989;30:599-604
2. Leveillé J, Demonceau G, DeRoo M, et al. Characterization of technetium-99m-L,L-ECD for brain perfusion imaging, part 2. Biodistribution and brain imaging in humans J Nucl Med 1989;30:1902-1910.
3. Holman BL, Heilman RS, Goldsmith SJ, et al. Biodistribution, dosimetry and clinical evaluation of technetium-99m-ethyl cysteinate dimer in normal subjects and in patients with chronic cerebral infarction. J Nucl Med 1989; 30:1018-1024.
4. Neurolite® package insert. Kit for the preparation of technetium-99m-bicisate injection North Billerica. MA: Du Pont Merck Pharmaceutical, 1994.
5. 113mIn-labeled stannous hydroxide as a potential multipurpose scanning agent [Abstract]. J Nucl Med 1971,12:467
6. Saha GB. Fundamentals of nuclear pharmacy, 3rd ed. New York: Springer Verlag; 1992.147-153.